The original online version of this article was revised: In this article it has been missed to include the Funding information during the production process
A slower titration schedule, spending more time at each dose level before increasing, gives the cardiovascular system time to recalibrate
I, so I take a thyroid medication because my, by the time everything was caught, it was a little bit too far
The most frequently reported adverse events (AEs) of GLP-1 RAs were gastrointestinal adverse drug reactions, including nausea, vomiting, and abdominal pain, which were closely related to activation of central and peripheral GLP-1 receptors ( In a recent network meta-analysis, overall GLP-1 RAs significantly increased the incidence of gastrointestinal AEs compared with placebo or conventional treatment, and the odds ratios for nausea, vomiting and diarrhea from GLP-1 RAs were 11.8 (95% CI, 2.8946.9), 51.7 (95% CI, 7.07415), and 4.93 (95% CI, 1.7514.7), respectively ( Methods Data sources This retrospective pharmacovigilance study was conducted based on the FDA Adverse Event Reporting System (FAERS) database
293 ZhangY.MaY.XiaoY.LuC.XiaoF
